艾昆纬-利用人工智能建模改进患者识别95x（英）-2023.4-15页_3mb

Summary of "Opportunities in Moving Care Nearer the Patient"

Introduction

The report explores the shift toward near-to-patient care, driven by patient-centricity and personalized medicine in healthcare, with COVID-19 accelerating its adoption. This involves structural changes in healthcare systems to treat patients closer to home, such as in outpatient settings, to enhance flexibility and outcomes.

Key Elements of Near-to-Patient Care

• Points of Administration: Includes outpatient clinics, mobile clinics, local pharmacies, and home care with or without healthcare professionals (HCPs), offering varied care endpoints to increase accessibility.
• Telehealth Solutions: Encompasses digital tools like teleconsultations, telediagnosis, and digital therapeutics (DTx), enabling remote monitoring and reducing in-person visits, with smartphones and IoT devices supporting data collection.
• Formulations and Devices: Emphasizes patient-friendly options like autoinjectors and hidden-needle devices, along with simpler formulations (e.g., subcutaneous, oral) to facilitate self-administration or basic facility use.

Challenges to Implementation

• Regulatory: Lack of harmonized policies across countries, such as restrictions in Spain and France on home drug delivery, create barriers to expansion.
• Financial: Insufficient financial frameworks and incentives lead to limited support, with budget constraints potentially diverting focus from near-to-patient care investments.
• Behavioral: Institutional inertia in healthcare systems and varying HCP confidence in telehealth slow adoption, while patient preferences and HCP resistance to new technologies complicate implementation.
• Logistical: Increased last-mile delivery points, storage challenges for specialized products (e.g., cold-chain requirements), and staffing shortages for expanded care exacerbate operational complexities.

Opportunities for Stakeholders

• Patients: Gain greater flexibility in time and location for treatments, improved access to healthcare, and enhanced convenience through options like home administration and telehealth.
• Healthcare Systems: Achieve cost savings by reducing hospital admissions, improve patient access to medicines, and leverage digital technologies for better efficiency, though human resource demands may offset some benefits.
• Pharma Companies: Expand market reach through increased patient access, develop patient-friendly formulations to differentiate products, and engage with policymakers to drive regulatory and financial support.
• Distributors: Benefit from new revenue streams via service provision in pharmacies and home deliveries, with investments needed for logistics and data handling.
• Pharmacies: Shift roles to include administration and monitoring, opening new revenue channels and requiring infrastructure upgrades for expanded services.